Why Oscar Health Inc’s (OSCR) Stock Is Down 8.30%

By Cynthia McLaughlin
March 01, 2023
Featured Tickers:

One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Oscar Health Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Oscar Health Inc’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Oscar Health Inc’s stock price such as:

  • Current stock price and volume
  • Stock price history
  • Upgrades and downgrades from analysts
  • Stock price momentum as measured by its relative strength

About Oscar Health Inc (OSCR)

Before we jump into Oscar Health Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Oscar Health, Inc. is a health insurance company that has built a full stack technology platform focused on serving its members. It is engaged in offering individual and family, small group, and Medicare advantage plans, and +Oscar platform. Its individual and small group consists of policies purchased by individuals and families through health insurance marketplaces. It offers health plans on the individual market on exchange and off-exchange under the five metal plan categories, such as catastrophic, bronze, silver, gold, and platinum. It offers Medicare advantage plans to adults who are age 65 and older and eligible for traditional Medicare. Its Campaign Builder is its +Oscar modularized solution, which is an engagement and automation platform that enables personalized interventions and automates workflows. Its health plans include access to a network of physicians and hospitals, as well as a personalized Care Team that supports members from finding a doctor to navigating costs.

Want to learn more about Oscar Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Oscar Health Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Learn More About A+ Investor

What Caused Oscar Health Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 28, 2023, there were 2 analysts who downgraded Oscar Health Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Oscar Health Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Oscar Health Inc’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Oscar Health Inc (OSCR) by visiting AAII Stock Evaluator.

Relative Price Strength of Oscar Health Inc

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of February 28, 2023, Oscar Health Inc has a weighted four-quarter relative price strength of 30.24%, which translates to a Momentum Score of 97 and is considered to be Very Strong.

Want to learn more about how Oscar Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Oscar Health Inc Stock Price: Bottom Line

As of March 1, 2023, Oscar Health Inc’s stock price is $5.08, which is down 8.3% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Oscar Health Inc’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Shaughnessy Tiny Titans
Screen:
23.7%
Annual Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.